Drugs
Home Page
Xagena Medicine
Xagena.net
2011 - Fluoroquinolones: risk of QT interval prolongation
Zortress to prevent organ rejection in adult kidney transplant recipients, FDA approved
Zometa: safety
Tribenzor, a three-in-one combination product for the treatment of hypertension
Edoxaban versus Enoxaparin in preventing venous thromboembolism after total knee replacement
Diabetes mellitus: FDA has restricted access to Avandia
Advanced non small cell lung cancer with EGFR activating mutations: Erlotinib first-line nearly triples progression free survival
MetMAb combined with Erlotinib in high MET expressing non-small cell lung cancer
Non-Hodgkin’s lymphoma: GA101, the first type II, glycoengineered anti-CD20 monoclonal antibody, demonstrates promising efficacy
FDA has begun process to remove breast cancer indication from Avastin label
Osteoporosis: atypical femur fractures associated to bisphosphonate use
Provenge, the first autologous cellular immunotherapy for patients with prostate cancer
PLX4032 selectivity blocks RAF/MEK/ERK signaling pathway
No benefit of prescription omega-3 fatty acids in prevention of recurrent symptomatic atrial fibrillation in affected patients
Anacetrapib significantly raises HDL cholesterol, cuts LDL cholesterol nearly in half
Afinitor in advanced renal cell carcinoma after failure of treatment with Sunitinib or Sorafenib
Osteoarthritis of the knee or hip: Samyr should not be routinary
Painful neuropathy or chronic pain: Duloxetine treatment
Cystic fibrosis: no benefit or harm with Vitamin-D supplementation
Moderate-level evidence of efficacy and safety for Orencia in rheumatoid arthritis
Antinflammatory drugs: coxibs interfere with Acetylsalicylic acid 's clotting ability
Rash and psychiatric symptoms linked to Provigil
Progressive multifocal leukoencephalopathy in patients treated with CellCept
Risk of peripheral neuropathy with Sebivo
Infections with the use of InductOs with reamed intramedullary nails for acute open tibia fractures
Fibrotic reactions with Pergolide
Preclinical safety information on teratogenicity of Revlimid
Cabaser and Dostinex associated with cardiac valvulopathy and fibrotic disorders
Progressive multifocal leukoencephalopathy linked to MabThera
Aspirin has no role in the prevention of myocardial infarctions in patients with diabetes
Next Pages [
1
]
2
3
4
5
6
7
8
9
10
»
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions